Migraine Abortive Treatment in Children and Adolescents in Israel
试验速览
- 阶段
- 不适用
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Migraine treatment
研究概览
简要总结
Migraine headaches in children and adolescents may cause severe attacks that require abortive treatment. This study evaluated the incidence and efficacy of medications used for relieving migraine headache attacks in the pediatric population in Israel. Children 6-18 years of age who were diagnosed in our pediatric neurology clinic as having migraine headaches were enrolled into the study. Children and their parents filled in questionnaires about their response to abortive treatment two hours after use, during three acute headache attacks. The questionnaire included demographic data, baseline headache intensity, migraine-associated symptoms, medications used, and pain assessment.
详细描述
Background: Headaches are a common complaint in children and adolescents. Most cases are caused by a benign problem or a primary headache disorder, such as migraine and tension-type headaches. Not enough research has been done about the effect of analgesics in treating acute primary headache attacks among children.
Study objective-This study's goal is to describe which medications are used for relieving primary headache attacks in outpatient pediatric population in Israel, and to evaluate their analgesic effect.
Methods: The study group will include 50 patients who were assessed in the pediatric neurology clinic and were diagnosed as having a primary headache.
Evaluation of the results via filled out surveys;
- First survey for headache assessment at the pediatric neurology clinic.
- Second survey for tracking given analgesic and its effect by the child at home in addition to checkup calls by pediatric staff.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 6 Years 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •children 6-18 years of age with migraine headaches. Need for headache abortive treatment -
排除标准
- •Secondary headache Systemic disease Mental Retardation
结局指标
主要结局
Migraine treatment
时间窗: 2 hours
improvement of headache severity
次要结局
未报告次要终点
研究者
Jacob.genizi
Director Pediatric Neurology Unit
Bnai Zion Medical Center